Showing results (221-230 of 1,186) with videos related to
Sort By:
Pageof 119
Pharmaceutical Statistics|March 27, 2015
Experimental designs for detecting synergy and antagonism between two drugs in a pre-clinical studyMatthew Sperrin, Helene Thygesen, Ting-Li Su, et al.Pharmaceutical Statistics|March 27, 2015
Letter to the editor by the authors of Exact Calculation of Power and Sample Size in Bioequivalence Studies Using Two One-sided Tests, Pharmaceutical Statistics, DOI: 10.1002/pst.1666Meiyu Shen, Estelle Russek-Cohen, Eric V SludPharmaceutical Statistics|April 9, 2015
Assessing the treatment effect in a randomized controlled trial with extensive non-adherence: the EVOLVE trialYumi Kubo, Lulu Ren Sterling, Patrick S Parfrey, et al.Pharmaceutical Statistics|July 19, 2012
The statistician's role in the prevention of missing dataSara Hughes, Julia Harris, Nancy Flack, et al.Pharmaceutical Statistics|March 27, 2023
Statistical methods for handling missing data to align with treatment policy strategyYun Wang, Wenda Tu, Yoonhee Kim, et al.Pharmaceutical Statistics|August 9, 2021
Incorporating covariates information in adaptive clinical trials for precision medicineWanying Zhao, Wei Ma, Fan Wang, et al.Pharmaceutical Statistics|February 16, 2023
Propensity score-based methods for causal inference and external data leveraging in regulatory settings: From basic ideas to implementationHeng Li, Lilly Q YuePharmaceutical Statistics|February 9, 2023
Bayesian single-to-double arm transition design using both short-term and long-term endpointsTianlin Xu, Haolun Shi, Ruitao LinPharmaceutical Statistics|March 7, 2023
Covariate handling approaches in combination with dynamic borrowing for hybrid control studiesChenqi Fu, Herbert Pang, Shouhao Zhou, et al.Pharmaceutical Statistics|November 26, 2025
Confidence Intervals for Validation of Analytical Procedures Under ICH Q2(R2)Paul Faya, Chad N Wolfe, Adam P RaukPageof 119